American Society of Hematology/LinkedIn
May 8, 2026, 18:23
How SCD Affects Daily Life in sub-Saharan Africa? – American Society of Hematology
American Society of Hematology shared a post on LinkedIn:
“Sickle cell disease is the most common inherited blood disorder worldwide, yet patient experiences vary significantly by region.
Data from the Sickle Cell World Assessment Survey (SWAY) show that individuals in sub-Saharan Africa are less likely to know their sickle cell variant and use standard treatments, including over-the-counter pain medications, antibiotics, and folic acid.
They are also more likely to manage vaso-occlusive crises at home or rely on alternative approaches. These results reflect variation in diagnosis, treatment patterns, and care delivery across regions.
Learn more in the press release.”

Other posts featuring ASH on Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support